Danone Pays €1 Billion for Huel While Big Food Retreats: Inside the Renew Strategy

While Nestlé announced its largest headcount reduction in modern history and Unilever completed the sale of $42.7 billion in food brands, Danone moved in the opposite direction. On March 23, 2026, the French dairy and nutrition giant agreed to acquire Huel for €1 billion. Huel's FY2025 revenue was £250 million. That is a 4x revenue multiple in a sector where legacy food assets are changing hands at 2.5x. The premium is not irrational. It is a signal about where Danone believes the next decade of food value is being created.

Q1 2026 — Solid Growth Against Real Headwinds

Danone reported Q1 2026 net sales of €6,708 million on April 22, a like-for-like increase of 2.7%, driven by volume/mix growth of 1.5% and price of 1.2%. Reported sales fell 2.0% due to a 5.6% currency drag — primarily the strength of the euro against the US dollar (-10%) and Chinese yuan (-5.3%). The quarter absorbed two material headwinds: ongoing distribution disruption in the Middle East from regional conflict, and a European infant formula recall that temporarily impacted its Specialized Nutrition division. Against that backdrop, a 2.7% LFL result keeps Danone on track for its full-year guidance of 3–5% LFL sales growth and recurring operating income growing faster than sales. The Essential Dairy Products division led with 3.4% LFL growth — protein, hydration, and functional dairy formats driving the result.

The €1 Billion Huel Bet

Huel is not a traditional food and beverage acquisition. The brand sells complete meal powders, ready-to-drink shakes, hot and savoury meals, nutrition bars, and functional beverages — every product designed to deliver all essential macronutrients and micronutrients in a single serve, in a plant-based format. Revenue grew 16% year-on-year to £250 million in FY2025. Its distribution model is predominantly direct-to-consumer, with subscription as a core revenue channel and a highly engaged community of customers in the UK, Europe, and the United States.

Why the Multiple Is Justified

The 4x revenue multiple is exactly where functional nutrition assets have been repricing. Unilever paid roughly $1.2 billion for Grüns — a gummy supplement brand founded in 2023 with $300 million in year-two revenue — days after closing the $42.7 billion McCormick food deal. PepsiCo paid $1.95 billion for Poppi and $1.2 billion for Siete Foods. Across the sector, brands that combine functional credibility, digital-first consumer relationships, and subscription economics are attracting a structural valuation premium over legacy CPG formats. The meal replacement market is projected to grow at a 7.5% CAGR through 2031. Huel is the global category leader by awareness. Danone is buying the leading position, not a follower.

The Arcor JV: Rationalizing the Legacy Dairy Book

On March 24 — the day after announcing the Huel deal — Danone announced a 50/50 joint venture with Argentina's Arcor group, incorporating Danone's EDP business in Argentina, Mastellone Hermanos (owner of the La Serenísima dairy brand), and a shared logistics subsidiary. The structure removes Danone's full ownership of a large but low-margin emerging-market dairy operation, replaces it with a proportionate stake in a larger, more efficient combined entity, and frees capital for higher-multiple redeployment. This is the Renew strategy in operational terms: reduce exposure to commodity dairy in competitive emerging markets, reinvest at premium multiples in nutrition platforms with structural growth tailwinds.

What the Renew Strategy Actually Means

Danone's Renew strategy — formally launched in 2023 under CEO Antoine de Saint-Affrique — is built on four commitments: concentrate on winning categories (protein, medical nutrition, plant-based, and functional dairy), divest or JV lower-return assets, acquire brands with digital distribution moats, and restructure the operating model to reduce complexity. The new three-zone structure (EMEA, Americas, APAC — effective January 1, 2026) is the structural backbone. Kate Farms — acquired in July 2025 as a medical nutrition asset with presence in 1,400 US hospitals and insurance coverage through Medicare and Medicaid — has already contributed positively to Q1 2026 scope effects.

The Divergence Is the Story

Big Food in 2026 is not monolithic. Nestlé is cutting 16,000 jobs and selling assets that were once trophy acquisitions. Unilever is exiting food entirely. But Danone is acquiring at scale, restructuring through joint venture rather than outright sale, and upgrading its growth profile through assets that command 4x revenue premiums. For executives, investors, and M&A advisors watching the sector, this divergence — between retreating incumbents and strategic acquirers — defines the next wave of opportunity and competitive risk. Danone's Huel deal will close subject to regulatory approval in H2 2026. When it does, the combined platform will hold Huel, Activia, Danone Medical Nutrition, Kate Farms, and Aptamil under a single strategic direction. The question is no longer whether Danone is rebuilding. It is whether the rebuild is moving fast enough to close the gap with the more visible transformation headlines of Nestlé and Unilever.